The US Food and Drug Administration will audit Bubs Australia’s Deloraine, canning facility in Victoria next week as the infant formula company further axes jobs at its US office.
Former Bubs CEO Kristy Carr and executive chairman Dennis Lin are also suing Bubs and the non-executive directors of the baby formula group – Katrina Rathie, Steven Lin, Reg Weine and Paul Jensen – in the Victorian Federal Court over their removal from the company co-founded by Ms Carr.
Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
